Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance

Giuseppe Viale, Leen Slaets, Femke A. de Snoo, Jan Bogaerts, Leila Russo, Laura van’t Veer, Emiel J T Rutgers, Martine J. Piccart-Gebhart, Lisette Stork-Sloots, Patrizia Dell’Orto, Annuska M. Glas, Fatima Cardoso

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance'. Together they form a unique fingerprint.

Medicine & Life Sciences